Home / Cancer and immune system / Sirolimus
ATC L01EG04 · Mammalian Target of Rapamycin (mTOR) Kinase Inhibitors · updated 2 Nov 2026
Sirolimus shortage
As of 2 Nov 2026, Sirolimus has a reported shortage in 1 of the 16 countries we track (France), covering 1 product from 0 companies.
Is there a Sirolimus shortage?
Yes. As of 2 Nov 2026, Sirolimus is reported short in 1 of the 16 countries we track: France. No company has given a return date.
Timeline
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Compared with similar medicines
ATC group L01EG · Mammalian Target of Rapamycin (mTOR) Kinase InhibitorsAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| FR | Rapamune 1 mg/ml, solution buvable limited | 24 Sep 2026 | not given | Not stated |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.
Questions
Is there a Sirolimus shortage?
Yes. As of 2 Nov 2026, Sirolimus is reported short in 1 of the 16 countries we track: France. No company has given a return date.
When will Sirolimus be back in stock?
No return date has been given; France: no date given. These are company estimates reported to each authority.
Why is Sirolimus in short supply?
The most common reason reported is: not stated. Reasons by product are listed in the table below.
Which companies have Sirolimus shortages?
The registers do not name the companies.